drugset / Trial / NCT01548703
A Multiple Ascending Dose Study of BCI-838 in Healthy Volunteers
RandomizedSingle-groupDouble-blindTreatment
Summary
This study will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of BCI-838 and its metabolite BCI-632 in healthy male and female subjects.
Timeline
- Start
- 2012-02
- Primary completion
- 2012-04
- Completion
- 2012-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MGS-0210 | Small molecule | 100 mg | Oral |
Indications
No indication recorded.